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INTRODUCTION
The chondrodysplasias are a heterogeneous group of rare genetic
diseases for which there are no effective therapies. Current research
is therefore focused on understanding disease mechanisms and
identifying potential therapeutic targets. The various
chondrodysplasia phenotypes can arise from a broad spectrum of
defects in either cartilage-specific structural proteins, metabolic
processes or growth plate regulation that ultimately disturb
endochondral ossification (Kornak and Mundlos, 2003; Warman et
al., 2011). However, it has become increasingly evident that two
interconnected pathways act synergistically to define the
chondrodysplastic phenotype. On the one hand, disease-causing
mutations disturb the complex extracellular matrix (ECM) network,
altering the mechanical properties of the ECM and interfering with
signalling pathways regulating endochondral ossification (Beier and
LuValle, 2002; Chen and Deng, 2005; Cortes et al., 2009; Ishijima et
al., 2012; Klüppel et al., 2005; Raducanu et al., 2009; Ruiz-Perez and
Goodship, 2009; Wang et al., 2002; Yoon et al., 2005). On the other
hand, intracellular stress is triggered in chondrocytes synthesising
mutant proteins, causing alterations in the secretory pathway,
disturbing normal cell metabolism and proliferation, and, in extreme
cases, leading to cell death (Nundlall et al., 2010; Piróg-Garcia et al.,
2007; Rajpar et al., 2009; Saito et al., 2009; Tsang et al., 2007).
Notwithstanding disease-specific features, phenotypically similar
chondrodysplasias that are caused by different mutations can
share some pathophysiological similarities. These can include the
retention of mutant protein, co-retention of other interacting
proteins, endoplasmic reticulum (ER) stress, reduced chondrocyte
proliferation, increased and/or spatially dysregulated chondrocyte
apoptosis, disturbed chondrocyte differentiation, and finally, altered
signalling pathways (Cortes et al., 2009; Forlino et al., 2005; Gualeni
et al., 2010; Nundlall et al., 2010; Piróg-Garcia et al., 2007; Posey
et al., 2009; Raducanu et al., 2009; Rajpar et al., 2009; Rodgers et
al., 2007; Sahni et al., 2001; Suleman et al., 2012; Wang et al., 2007;
Wang et al., 2002). Therefore, delineating the relative contributions
of intra- and extracellular disease mechanisms and evaluating the
comparative influences of reduced chondrocyte proliferation and
increased or dysregulated apoptosis on long bone growth are major
challenges in understanding disease pathology in a broad range of
genetic skeletal diseases, and is a prerequisite for identifying
therapeutic targets.
Targeted transgenic mice, such as those modelling
pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia
Disease Models & Mechanisms 6, 1414-1425 (2013) doi:10.1242/dmm.013342
1Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University
of Manchester, Manchester, M13 9PT, UK
2University of Michigan Health System, Ann Arbor, MI 48109, USA
*Present address: Institute of Genetic Medicine, Newcastle University, International
Centre for Life, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK
‡Author for correspondence (michael.briggs@newcastle.ac.uk)
Received 14 June 2013; Accepted 5 September 2013
© 2013. Published by The Company of Biologists Ltd
This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution
and reproduction in any medium provided that the original work is properly attributed.
SUMMARY
Disease mechanisms leading to different forms of chondrodysplasia include extracellular matrix (ECM) alterations and intracellular stress resulting
in abnormal changes to chondrocyte proliferation and survival. Delineating the relative contribution of these two disease mechanisms is a major
challenge in understanding disease pathophysiology in genetic skeletal diseases and a prerequisite for developing effective therapies. To determine
the influence of intracellular stress and changes in chondrocyte phenotype to the development of chondrodysplasia, we targeted the expression
of the G2320R mutant form of thyroglobulin to the endoplasmic reticulum (ER) of resting and proliferating chondrocytes. Previous studies on this
mutant protein have shown that it induces intracellular aggregates and causes cell stress and death in the thyroid gland. The expression and retention
of this exogenous mutant protein in resting and proliferating chondrocytes resulted in a chronic cell stress response, growth plate dysplasia and
reduced bone growth, without inducing any alterations to the architecture and organization of the cartilage ECM. More significantly, the decreased
bone growth seemed to be the direct result of reduced chondrocyte proliferation in the proliferative zone of growth plates in transgenic mice,
without transcriptional activation of a classical unfolded protein response (UPR) or apoptosis. Overall, these data show that mutant protein retention
in the ER of resting and proliferative zone chondrocytes is sufficient to cause disrupted bone growth. The specific disease pathways triggered by
mutant protein retention do not necessarily involve a prototypic UPR, but all pathways impact upon chondrocyte proliferation in the cartilage
growth plate.
A novel transgenic mouse model of growth plate
dysplasia reveals that decreased chondrocyte
proliferation due to chronic ER stress is a key factor in
reduced bone growth
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(MED) caused by antimorphic mutations in cartilage oligomeric
matrix protein (COMP: p.D469del and p.T585M; PSACH) and
matrilin-3 (p.V194D; MED), have established that mutant protein
retention causes chronic ER stress, reduced chondrocyte
proliferation, increased and/or spatially dysregulated apoptosis, and
abnormal changes to the organisation and architecture of the ECM
(Bell et al., 2013; Leighton et al., 2007; Nundlall et al., 2010; Piróg-
Garcia et al., 2007; Suleman et al., 2012). However, the complex
pathology of PSACH and MED cannot readily be dissected in these
mouse models and only through the use of novel transgenic mouse
approaches can we begin to delineate the relative contributions of
these interconnected disease pathways.
In this context, the aim of this study was to dissect the relative
contribution of intracellular stress in resting and proliferating
chondrocytes to the development of chondrodysplasia by targeting
the expression of an exogenous mutant protein, known to accumulate
in the ER and trigger intracellular stress, predominantly in these cell
types. This approach was achieved by expressing the G2320R mutant
form of thyroglobulin (Tg) under the collagen type II promoter to
generate a novel mouse model. A similar approach has been used
previously to generate a mouse model expressing the L2263P mutant
form of Tg (Rajpar et al., 2009), known to induce ER stress (Kim et
al., 1996), exclusively in hypertrophic chondrocytes. This mouse
model confirmed the central role of hypertrophic chondrocyte ER
stress in the pathogenesis of metaphyseal dysplasia type Schmid
(MCDS). However, owing to the restricted expression of type X
collagen to hypertrophic chondrocytes, both this novel phenocopy
and also targeted mouse models of MCDS are not able to address
the fundamental role of chronic ER stress in chondrocytes within
the resting and proliferative zone, which are the essential precursors
for hypertrophy.
Tg is a 660-kDa homodimeric protein produced by the thyroid
gland. It is the major secretory glycoprotein produced by thyrocytes
and is the precursor protein for thyroid hormone synthesis
(Malthièry et al., 1989). During synthesis in the ER, Tg monomers
assemble to form large multimers associated with ER-resident
molecular chaperones. Monomers released from these complexes
can then be glycosylated and subsequently dimerize to form the
mature protein (Lee et al., 2009), with the cholinesterase-like
(ChEL) domain at the C-terminus of the protein being important
for Tg dimerization (Lee et al., 2008). The spontaneous G2320R
missense mutation in the ChEL domain of Tg is responsible for
congenital hypothyroidism in rdw/rdw rats (Kim et al., 2000)
through a mechanism that involves protein retention in the ER and
ablated synthesis of thyroid hormones. The Tg-G2320R protein
(Tgrdw) that accumulates in the ER is misfolded with abnormal and
persistent exposure of free cysteine thiols, which results in the
strong binding of ER-resident oxidoreductases [in particular ERp72,
but also protein disulfide-isomerase (PDI) and ERp57]. The
association of Tgrdw with ERp72 is believed to render a subfraction
of the mutant Tg resistant to ER-associated degradation (ERAD)
and leads to cell death, suggesting a possible gain of toxic function
(antimorphic) for the mutant protein in thyrocytes (Menon et al.,
2007).
In this study we generated transgenic mice expressing Tgrdw
under the collagen type II promoter (Col2-Tgrdw mice), thereby
causing intracellular stress predominantly in resting and
proliferating chondrocytes, and observed that transgenic mice
develop a severe chondrodysplasia without any detectable
alterations to ECM composition or increased levels of chondrocyte
apoptosis. We show that intracellular stress alone, in the absence
of transcriptional activation of the unfolded protein response
(UPR), is sufficient to cause chondrodysplasia through reduced
chondrocyte proliferation.
RESULTS
Generation of transgenic mice expressing Tgrdw under the Col2
promoter
The expression of Tgrdw was targeted to mouse chondrocytes by
the type II collagen promoter (Col2-Tgrdw) and, for easier detection
of the mutant protein, three Myc tags were included at the C-
terminus of the transgenic protein (Fig. 1A; supplementary material
Fig. S1). Transgenic mice were generated by pronuclear injection
and two independent lines that had incorporated the transgene
TRANSLATIONAL IMPACT
Clinical issue
Chondrodysplasias are a clinically and genetically heterogeneous group of rare
diseases for which there are no effective treatments. To identify potential
therapeutic targets for these debilitating genetic skeletal disorders, current
research is focused on understanding the underlying pathogenic mechanisms.
Disease mechanisms leading to different forms of chondrodysplasia include
extracellular matrix (ECM) alterations and intracellular stress leading to
abnormal changes in chondrocyte proliferation and survival. Delineating the
relative contribution of these interconnected mechanisms to disease onset is a
major challenge. Targeted transgenic mouse models of specific
chondrodysplasias have established that mutant protein expression causes
chronic endoplasmic reticulum (ER) stress, reduced chondrocyte proliferation,
increased and/or spatially dysregulated apoptosis, and abnormal changes to
the organization and architecture of the ECM. The complex pathology of these
diseases cannot be readily dissected in these targeted mouse models,
highlighting the need to develop novel transgenic mice that can be used to
assess the distinct effects of intracellular stress and ECM alterations on
chondrocytes and growth plate pathology. 
Results
The authors targeted the expression of a mutant version of thyroglobulin, a
protein known to accumulate in the ER and trigger intracellular stress in the
thyroid gland, to chondrocytes in mice. The expression and retention of this
exogenous mutant protein in resting and proliferating chondrocytes resulted
in a chronic cell stress response, growth plate dysplasia and reduced bone
growth, without inducing any alterations to the architecture and organization
of the cartilage ECM. Interestingly, the decreased bone growth was the direct
result of reduced chondrocyte proliferation in the proliferative zone of
transgenic mouse growth plates and did not involve transcriptional activation
of a classical unfolded protein response (UPR) or apoptosis.
Implications and future directions
This work provides a novel transgenic model for investigating the role of
intracellular stress in chondrodysplasia development. Future studies using this
transgenic model will identify new therapeutic targets and provide novel
diagnostic and prognostic biomarkers for these diseases. Moreover, this study
shows for the first time that mutant protein retention in the ER of
chondrocytes is sufficient to cause disrupted bone growth by reducing
chondrocyte proliferation. Intriguingly, the specific disease pathways triggered
by mutant protein retention do not necessarily involve a prototypic UPR. This
finding compels a paradigm shift in our understanding of ER stress in the
context of genetic diseases. Understanding why and how different misfolded
mutant proteins evoke UPR-independent stress pathways is an exciting new
area in human pathobiology.
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(Fig.  1B) and expressed Tgrdw in chondrocytes (Fig.  1C) were
analyzed separately in the first instance. We also confirmed that
Tgrdw protein expression was localized to type-II-collagen-
expressing chondrocytes found in the growth plate, costal and
articular cartilages (Fig. 1D; supplementary material Fig. S1). The
intracellular accumulation of mutant Tgrdw protein in the
chondrocytes of newborn Col2-Tgrdw mice is consistent with
targeted mouse models of PSACH, MED and MCDS, and confirms
that mutant protein retention (i.e. Tgrdw, COMP, matrilin-3 and type
X collagen) precedes the onset of clinical symptoms such as
reduced bone growth (supplementary material Table S1).
By real-time qPCR on genomic DNA, we observed that a larger
transgene copy number was present in one mouse line compared
with the other (our unpublished observations), but all subsequent
analyses showed no discernible differences in the morphological
and biochemical phenotype of the two lines, and therefore data
obtained from the two lines were pooled where appropriate for the
final analyses. Measurements obtained from male and female mice
followed similar trends and the data presented herein are from the
males.
The expression of Tgrdw in chondrocytes causes short-limb
dwarfism in transgenic mice
Transgenic mice expressing Col2-Tgrdw were viable and were either
normal or slightly smaller than wild-type mice at birth. This finding
is consistent with our previously published targeted mouse models
of chondrodysplasia (supplementary material Table S1) and is a
well-documented clinical feature in individuals with PSACH, MED
and MCDS (Briggs and Chapman, 2002; Lachman et al., 1988;
Leighton et al., 2007; Piróg-Garcia et al., 2007; Rajpar et al., 2009;
Suleman et al., 2012).
By 3 weeks of age, Col2-Tgrdw mice were significantly lighter than
their wild-type equivalents (Fig. 2A). For example, at 3 weeks of
age transgenic mice were 35.5% lighter (P<0.0001), at 6 weeks they
were 16.6% lighter (P<0.0001) and finally by 9 weeks they were
14.9% lighter (P<0.0001) than age-matched wild-type mice (n≥19
mice per genotype).
At 3 weeks of age the long bones of Col2-Tgrdw mice were shorter
than those of age-matched wild-type controls, signifying a defect
in endochondral bone growth (Fig.  2B). Indeed, the femurs and
tibiae of Col2-Tgrdw mice were significantly shorter than age-
matched controls (Fig. 2B-E; P<0.0001) at all time points examined
(3 weeks: 8.8% and 8.1%, 6 weeks: 6.4% and 4.6%, and 9 weeks:
7.7% and 4.9%, respectively; n≥30 mice per genotype). However,
the inner canthal distance (ICD) in transgenic animals was the same
as controls at all ages analyzed (n≥16 mice per genotype),
confirming that the expression of the transgene affected
endochondral and not intramembranous bone formation (Fig. 2B).
A mild hip dysplasia characterized by an increase in the angle
of deflection from the vertical of the tuberosity of the ischium was
detected in ~4% of Col2-Tgrdw mice from 3 weeks of age (Fig. 2F).
This feature is often reported in other targeted mouse models of
chondrodysplasias, including those of PSACH (Piróg-Garcia et al.,
2007; Suleman et al., 2012).
Col2-Tgrdw mouse growth plates are dysplastic with disorganized
chondrocyte columns and distinct areas of hypocellularity, but
with no major alteration to the cartilage ECM
The overall development of the growth plate and formation of the
secondary centre of ossification was relatively normal in Col2-Tgrdw
transgenic mice up to 3 weeks of age (Fig. 3; supplementary material
Fig. S2). The different zones of the growth plate (resting,
proliferating and hypertrophic) were clearly distinguishable
(Fig.  3A1,B1; with higher magnification shown in A2 and B2),
although some abnormal areas of hypocellularity were apparent in
the growth plates of transgenic mice (Fig.  3B2; red asterisks).
Moreover, in some, but not all, Col2-Tgrdw growth plates the
chondrocyte columns in the proliferative zone were grossly
disorganized and this pathological feature presented as a continuum
from mild to severe (supplementary material Fig. S3).
Morphometric analysis confirmed that there were no differences
in the overall width of the growth plate (wild type 246±15 μm; Col2-
Tgrdw 209±12 μm) or the relative proportions of the resting (wild
type 11±1%; Col2-Tgrdw 13±1%), proliferative (wild type 52±2%;
Fig. 1. Generation of the Col2-Tgrdw transgenic mouse model. (A) Schematic
of the transgene showing how the expression of G2320R (rdw) thyroglobulin
(Tg) was driven by the type II collagen (Col2) promoter (Col2-Tgrdw). Three Myc
tags (Myc) were included at the C-terminus of the transgenic protein to allow
detection. (B) Agarose gel electrophoresis of PCR-amplified mouse genomic
DNA. A distinct band at ~360 bp was observed in both Col2-Tgrdw transgenic
animals (rdw1 and rdw2), whereas no DNA product was amplified from wild-
type animals (wt). Hyperladder IV was used as molecular weight marker (Lad).
(C) Western blot analysis demonstrating that a band at ~330 kDa, consistent
with the size of Tgrdw (including tags), was detected in Col2-Tgrdw transgenic
mice (rdw1 and rdw2) using an anti-Myc antibody (c-Myc). Comparable levels
of transgene protein were detected in the two different Col2-Tgrdw lines,
whereas no transgene expression was observed in wild-type animals (wt). 
(D) Immunohistochemistry using an anti-Myc antibody demonstrated that no
transgenic protein was detected in the growth plate cartilage of newborn or
3-week-old wild-type mice (wt), whereas mutant Tgrdw transgenic protein was
clearly retained within chondrocytes of growth plate and articular cartilages of
the two transgenic lines (rdw1 and rdw2) at birth and at 3 weeks of age. There
was no evidence of mutant Tgrdw transgenic protein secretion in the cartilage
ECM of either mouse line. Scale bars: 100 μm.
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Col2-Tgrdw 49±1%) and hypertrophic (wild type 37±1%; Col2-Tgrdw
38±1%) zones. Furthermore, the number of hypertrophic
chondrocytes in individual cell columns within the hypertrophic
zone did not differ between genotypes (wild type 6.76±0.4; Col2-
Tgrdw 6.52±0.17) (supplementary material Fig. S4; three sections
per mouse and three mice per genotype were analyzed).
Importantly, mutant Tgrdw protein retention did not cause
significant co-retention of key cartilage ECM proteins. For example,
type II collagen (Fig. 3A3,B3), type X collagen (Fig. 3A4,B4), aggrecan
(Fig. 3A5,B5) and COMP (Fig. 3A6,B6) were secreted and normally
distributed in the cartilage ECM of transgenic mice. In addition, mass
spectrometry (MS)-based proteomics was also performed on
sequential cartilage extractions to study the differential extractability
of structural ECM components from the cartilage of wild-type and
transgenic animals. This analysis confirmed that the retention of
mutant Tgrdw protein did not cause alterations to the extractability
of 29 structural ECM components from the cartilage of 3-week-old
mice (supplementary material Table S2), thereby confirming that the
organization and integrity of the cartilage ECM was not significantly
affected in Col2-Tgrdw mice. The only significant differences were:
α1(IX) collagen and osteomodulin, which showed increased
extractability from Col2-Tgrdw cartilage in buffer 1; α1(II) collagen,
which was less extractable from Col2-Tgrdw cartilage in buffer 1;
α3(VI) collagen and fibronectin, which were both more easily
extracted from Col2-Tgrdw cartilage in buffer 2. This disease profile
contrasts sharply with targeted mouse models of PSACH-MED in
which there are highly significant differences in the extractability of
numerous cartilage structural proteins including various collagens,
small leucine-rich proteoglycans and tenascins (supplementary
material Table S2) (Bell et al., 2013).
The proteomic observations were supported in part by
microarray analysis performed on the mRNA isolated from
chondrocytes extracted from the cartilage of 5-day-old mice. This
study did not show any major changes in the relative expression
of 30 genes encoding cartilage structural proteins, with the
exception of a slight but statistically significant downregulation
in the expression of matrilin 1 (Matn1, −1.51-fold) and type X
collagen (Col10a1, −1.61-fold) in Col2-Tgrdw mice (supplementary
material Table S3). However, the comparison of these data sets
is limited because total protein quantity and their relative
extractability will not necessarily be representative of gene
expression levels.
A transcriptional UPR is not induced in the chondrocytes of Col2-
Tgrdw transgenic mice
We hypothesized that ER accumulation of the mutant transgenic
protein and the resulting ER stress might trigger the UPR or an
oxidative stress response in the chondrocytes of Col2-Tgrdw
transgenic mice, similar to that observed in thyrocytes (Menon et
al., 2007). Western blot analysis of total proteins extracted from
the chondrocytes of 5-day-old mice showed increased levels of BiP
(~twofold, P<0.0001), PDI (~threefold, P<0.01) and ERp72 (PDIA4;
~twofold, P<0.001), but normal levels of ERp57 (PDIA3) in Col2-
Tgrdw mice (Fig. 4A,B); increased levels of GRP94 in Col2-Tgrdw
chondrocytes was confirmed by MS (Fig. 4C). We also analyzed
the cartilage proteome generated by liquid-
chromatography–tandem-mass-spectrometry (LC-MS/MS), which
allowed us to determine the relative levels of an additional 20
chaperone proteins from 3-week-old mouse cartilage (Table 1). This
analysis only identified significant differences in the levels of
calreticulin (Calr: wild type: 4; Col2-Tgrdw: 8; P<0.05) and
peroxiredoxin 1 (Prdx1: wild type: 4; Col2-Tgrdw: 9; P<0.03). These
global findings were in contrast to candidate SDS-PAGE and
western blotting (Fig. 4B), which showed moderate but significant
increases in several chaperones and PDIs; these discrepancies might
be due to the differences in the age of the mice used between the
two studies (5 days versus 3 weeks).
To identify the range of proteins (such as chaperones and
foldases) that either interact directly with Tgrdw or are present in
‘folding complexes’, we performed immunoprecipitation on the
intracellular protein pool extracted from the chondrocytes of 5-
day-old Col2-Tgrdw mice. A subfraction of the immunoprecipitate
Fig. 2. Col2-Tgrdw transgenic mice develop a
short-limb dwarfism. (A) The weights of wild-
type (wt; solid line) and Col2-Tgrdw transgenic
(rdw; dashed line) mice were collected at 3, 6 and
9 weeks of age. Col2-Tgrdw animals were
significantly lighter than age-matched controls at
all the age points analyzed (***P<0.0001). 
(B) Bone length measurements of the femur, tibia
and inner canthal distance (ICD) of wild-type (wt;
white columns) and Col2-Tgrdw (rdw; black
columns) animals. The long bones of transgenic
mice were significantly shorter than normal at all
the age points examined (***P<0.0001), whereas
ICD was not affected by the expression of the
Col2-Tgrdw transgene. (C-E) Bone measurements
were performed on radiographies of wild-type
(wt) and transgenic (rdw) mice at 3 (C), 6 (D) and 9
(E) weeks of age. Scale bars: 15 mm. (F)
Radiographs of the pelvis of 3-week-old wild-type
(wt) and transgenic (rdw) mice, demonstrating
the hip dysplasia that Col2-Tgrdw animals
occasionally developed.
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was used to verify the expected presence of Tgrdw (Fig.  4D),
whereas the remainder was analyzed by LC-MS/MS to identify co-
precipitating proteins. Tgrdw interacted primarily with PDIA6, BiP
and a number of ribosomal proteins (Table 2). Surprisingly, in this
pull-down assay we were not able to detect an interaction between
Tgrdw and other members of the PDI protein family such as PDIA4,
even though the relative levels were increased in Col2-Tgrdw mutant
chondrocytes (see Fig. 4A,B).
We next performed real-time qPCR and microarray analysis
on mRNA extracted from the chondrocytes of 5-day-old mice to
determine the transcriptional consequences of expressing Tgrdw.
This time point was specifically chosen because we and others
have previously shown that mutant protein retention at birth
elicits a robust UPR in mouse models of MED and MCDS by 5
days of age (Cameron et al., 2011; Nundlall et al., 2010; Rajpar et
al., 2009). Real-time qPCR showed no relative increase in the
mRNA levels of BiP, CRT, ERp72 (PDIA4) or GRP94 in Col2-Tgrdw
compared with wild-type mice (Fig.  4E). This finding was also
confirmed by microarray analysis, which demonstrated that the
mRNA levels of more than 150 genes associated with ER stress,
ERAD and proteasomal degradation were normal in Col2-Tgrdw
mice, although slight (but statistically significant) changes were
observed for a few genes, including: activation transcription factor
3 (Atf3, −1.26-fold), insulin-like growth factor 1 (Igf1, +1.92-fold),
dolichol-phosphate (beta-D) mannosyltransferase 2 (Dpm2,
+1.31-fold), proteasome (prosome, macropain) subunit, alpha
type 4 (Psma4, +1.18-fold), proteasome (prosome, macropain)
subunit, alpha type 7 (Psma7, +1.42-fold), DnaJ (Hsp40) homolog,
subfamily C, member 9 (Dnajc9, +1.39-fold), DnaJ (Hsp40)
homolog, subfamily C, member 15 (Dnajc15, +1.32-fold) and heat
shock protein c171 (Hspc171, +1.42-fold) (supplementary
material Table S3).
Overall, these data provide evidence of a moderate cellular stress
in the absence of a classical transcriptional UPR. However, ER-
resident chaperones and oxidoreductases did interact with Tgrdw
and this might have been sufficient to prevent a UPR.
The levels of chondrocyte apoptosis are normal, whereas
proliferation is significantly decreased in the growth plates of
Col2-Tgrdw mice
The relative level of chondrocyte apoptosis was evaluated by
TUNEL using proximal sections of the tibial growth plate of 3-
week-old mice. TUNEL-positive cells were primarily localized at
the vascular invasion front in both Col2-Tgrdw and wild-type mice
(our unpublished observations). The number of TUNEL-positive
cells per total number of cells was comparable in the hypertrophic
zone of Col2-Tgrdw and wild-type mice (2.00±0.99% and 2.41±1.45%,
respectively; P=0.71, three sections per mouse and three mice per
genotype were analyzed). Furthermore, a similar limited number
of TUNEL-positive cells were detected in the proliferative zone of
both transgenic and wild-type animals (0.30±0.09% and 0.40±0.24%,
respectively; P=0.81) (Fig. 5A).
The relative levels of chondrocyte proliferation were evaluated
on the tibial growth plates of mice when growth rate is maximal
at 3 weeks of age (Vanky et al., 1998). The proportion of BrdU-
positive proliferative chondrocytes was significantly lower in Col2-
Tgrdw mice compared with controls (7.65±0.33% and 9.73±0.46%,
respectively; P<0.01, three sections per mouse and three mice per
genotype were analyzed), indicating that proliferation in the growth
plates of transgenic mice was significantly reduced by 21% (Fig. 5B).
Microarray analysis of mRNA isolated from chondrocytes
extracted from 5-day-old mice did not show any major differences
in the relative expression of 21 genes associated with apoptosis.
However, slight but statistically significant downregulation in the
expression of mitogen-activated protein kinase kinase kinase 5
(Map3k5, −1.59-fold), nuclear factor of kappa light polypeptide gene
enhancer in B-cells 1 (Nfkb1, −2.01-fold), tribbles homolog 3
(Trib3, −1.62-fold) and cach, cation transport-like regulator 1
(Cach1, −1.33-fold) was observed in Col2-Tgrdw mice
(supplementary material Table S3). In contrast, we confirmed the
significant downregulation of several genes involved in cell
proliferation, such as activin A receptor type 2 (Acvr2a, −4.00-fold),
fibroblast growth factor 10 (Fgf10, −3.51-fold), fibroblast growth
factor 1 (Fgf1, −4.13-fold), met proto-oncogene (Met, −5.44-fold)
and nucleus accumbens associated 1 (Nacc1, −3.07-fold).
DISCUSSION
Disturbed ECM networks, alterations in signalling pathways and
intracellular stresses have each been suggested, either separately
or in combination, as significant mechanisms contributing to
disease pathogenesis in a number of different forms of
chondrodysplasia (Cortes et al., 2009; Esapa et al., 2012; Forlino et
al., 2005; Gualeni et al., 2010; Nundlall et al., 2010; Piróg-Garcia et
al., 2007; Posey et al., 2009; Raducanu et al., 2009; Rajpar et al.,
Fig. 3. The overall architecture and ECM composition in the growth
plate of transgenic mice is normal. The extension and organization of
the growth plate was similar in wild-type (wt) and transgenic (rdw)
animals (A1 and B1, respectively; close ups in A2 and B2), even though
more areas of hypocellularity were detected in the growth plates of
Col2-Tgrdw mice (see red asterisks in B2). The relative levels and
distribution of important ECM structural molecules such as type II
collagen (Col2; A3 and B3), type X collagen (Col10; A4 and B4),
aggrecan (Agn; A5 and B5) and cartilage oligomeric matrix protein
(COMP; A6 and B6) in the growth plates of Col2-Tgrdw mice were
comparable to those in wild-type animals. Scale bars: 100 μm.
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2009; Rodgers et al., 2007; Sahni et al., 2001; Wang et al., 2007;
Wang et al., 2002). We have previously established the underlying
importance of ER stress in the development of MCDS by targeting
expression of the ER-stress-inducing cog mutant form of Tg
exclusively to hypertrophic chondrocytes (Rajpar et al., 2009). In
the current study we wished to determine the relative contribution
of intracellular stress, induced predominantly in resting and
proliferating chondrocytes, to growth plate pathology. A similar
stress is sufficient to induce apoptosis and has been associated with
severe pseudoachondroplasia (PSACH) caused by the Comp
D469del mutation (Suleman et al., 2012). We therefore generated
a transgenic mouse model expressing the apoptosis-inducing
G2320R mutant form of Tg (Menon et al., 2007) under the collagen
type II promoter (Col2-Tgrdw mice).
Col2-Tgrdw mice were either normal or slightly smaller at birth
compared with wild type, but became visibly smaller than wild-
type mice by 5 days of age. By 3 weeks of age transgenic animals
were significantly lighter than wild-type controls and had developed
an obvious short-limb dwarfism. As expected, intramembranous
ossification was not affected in Col2-Tgrdw mice. The delay in
phenotypic presentation is consistent with several other targeted
mouse models of chondrodysplasia in which mutant mice appear
relatively normal at birth, but develop a short-limb dwarfism with
increasing age (Cortes et al., 2009; Forlino et al., 2005; Piróg-Garcia
et al., 2007; Posey et al., 2009; Rajpar et al., 2009; Sogawa et al.,
2007; Suleman et al., 2012), and is also consistent with the clinical
progression of the disease in some affected individuals. For example,
individuals with PSACH and MED are normal at birth but start
exhibiting progressive short-limb dwarfism during early childhood
(Maroteaux and Lamy, 1959; Shivanand et al., 2007). Interestingly,
from 3 weeks of age transgenic mice occasionally exhibited hip
dysplasia, which is a feature reported in other mouse models of
chondrodysplasia (Forlino et al., 2005; Piróg-Garcia et al., 2007;
Rajpar et al., 2009; Rodgers et al., 2007; Suleman et al., 2012).
However, this phenotypic feature was only present in a small
proportion of Col2-Tgrdw mice, suggesting variable expressivity.
The development of the growth plate was essentially normal in
transgenic animals, with a typical vascular invasion front and
characteristic formation of the secondary ossification centre. The
resting, proliferating and hypertrophic zones of the growth plate
were clearly distinguishable in Col2-Tgrdw mice at 3 weeks of age,
and the relative size of the different zones was normal. Interestingly,
the growth plate in a small proportion of transgenic mice seemed
to be more severely affected, showing disorganization to the
columnar alignment of proliferating chondrocytes that could range
from mild to severe. However, the level of growth plate
disorganization did not correlate with the severity of the
chondrodysplastic phenotype, confirming the variable expressivity
of this pathological feature.
Proteomic analysis (co-immunoprecipitation and MS) confirmed
that, in chondrocytes expressing Tgrdw, the mutant protein formed
complexes with ER-resident chaperones and oxidoreductases; a
similar observation was previously noted in thyrocytes (Menon et
al., 2007). However, some of the interacting proteins were different
from those observed in thyrocytes, suggesting cell-specific
chaperone-foldase complexes. Conversely, no UPR or ERAD, or
increased proteasomal degradation markers, were detected at the
mRNA level at 5 days of age, suggesting that the apparent increase
in the protein levels of ER chaperones and oxidoreductases might
be due to increased protein half-life as previously reported (Menon
et al., 2007) or their sequestration in mutant Tg complexes and/or
aggregates, rather than to an increase in the relative expression of
these genes. Indeed, under conditions of chronic ‘low-grade’ ER
stress, BiP protein half-life is such that it does accumulate even
under conditions in which transcription of BiP is not increased
(Rutkowski et al., 2006). Alternatively, these specific chaperones
and foldases might be translationally regulated, thereby influencing
their relative levels in the mutant cell as a consequence of ER stress.
For example, it has been suggested that cells can develop an adaptive
response to mild ER stress through post-transcriptional and post-
translational mechanisms (Rutkowski et al., 2006). Proteomic
profiling of cartilage from 3-week-old mice identified at least 20
Fig. 4. Tgrdw aggregates with ER-resident oxidoreductases and PDIs, but
no transcriptional UPR is triggered in the chondrocytes of transgenic
mice. (A) Representative western blots of the total protein extracted from
chondrocytes of 5-day-old wild-type (wt) and Col2-Tgrdw (rdw) mice analyzed
for BiP, ERp72, PDI, ERp57 and GAPDH as a loading control. (B) Densitometry
analysis was performed on western blots of three different biological
replicates and showed significantly increased levels of BiP, PDI and ERp72 in
Col2-Tgrdw chondrocytes compared with wild type (*P<0.01; **P<0.001;
***P<0.0001), whereas no difference was detected in ERp57. (C) Proteins
extracted from 5-day-old wild-type (wt) and Col2-Tgrdw (rdw) mouse
chondrocytes were separated on a 4-12% SDS-PAGE gel and stained with
InstantBlue Coomassie to visualize the full protein profile of the two different
genotypes. The only major detectable difference was a band at ~97 kDa that
was present in Col2-Tgrdw mice and absent in controls (black frame). After
excision and analysis by mass spectrometry, the protein was found to
correspond to GRP94. (D) Tgrdw was immunoprecipitated using an anti-Myc
antibody conjugated with agarose beads. The expected precipitation of the
transgenic protein was verified by western blotting before proceeding with
mass spectrometry to identify co-precipitating proteins. A correctly sized band
at 330 kDa was detected in Col2-Tgrdw mice (rdw), whereas no band was
detected in controls (wt). (E) Real-time qPCR showed that the relative mRNA
levels of GRP94, BiP, ERp57 (PDIA3), calreticulin (CRT) and calnexin (CNX)
transcripts were normal in the chondrocytes of Col2-Tgrdw mice.
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different chaperones and foldases; however, only the levels of
calreticulin and peroxiredoxin 1 were significantly increased in
mutant cartilage, suggesting that chondrocytes have adapted to the
ER stress by this stage of the disease. A similar proteomic approach
confirmed a robust UPR in chondrocytes expressing the V194D
mutant form of matrilin-3, with significantly increased protein
levels of BiP (Hspa5), Hsp47, PDIA1, PDIA3, PDIA4, PDIA6, Grp94
(Hsp90b1) and calreticulin (Bell et al., 2013).
Although our finding that the accumulation of mutant Tgrdw did
not induce a transcriptional UPR was somewhat unexpected, there
have been other reports of novel stress pathways in models of
human diseases that are UPR-independent. Indeed, we have
recently shown that, in both cell and mouse models of PSACH
caused by COMP D469del, there is no evidence of a UPR (Suleman
et al., 2012), whereas cell models of osteogenesis imperfecta caused
by triple helical mutations in type I collagen do not show increased
Table 1. Chaperone proteins identified in the cartilage of wild-type and Col2-Tgrdw mice by spectral counting 
Gene product wt 1 wt 2 wt 3 rdw 1 rdw 2 rdw 3 wt mean rdw mean P-value 
Hspa5/Grp78/BiP 41 37 41 40 43 42 39.67 41.67 0.92 
Hspa8/Hspa10 33 48 39 39 32 45 40 38.67 0.63 
Hsp47/Serpinh1 28 35 31 28 31 29 31.33 29.33 0.48 
PDIA1 34 23 30 32 36 29 29 32.33 0.63 
Hsp90ab1 25 23 22 23 25 22 23.33 23.33 0.82 
Hsp90b1/Grp94 21 21 26 25 23 14 22.67 20.67 0.49 
Pdia3/Erp57 23 21 21 23 21 12 21.67 18.67 0.30 
Ppia/Cyclophilin A 8 15 12 15 12 11 11.67 12.67 0.85 
Ppib/Cyclophilin B 9 7 18 8 14 6 11.33 9.33 0.45 
Pdia4/Erp72 12 2 10 11 6 8 8 8.33 0.90 
Calreticulin 2 5 5 9 11 5 4 8.33 0.05* 
Prdx1 6 3 4 7 10 11 4.33 9.33 0.03* 
P4ha1 14 5 7 9 5 9 8.67 7.67 0.63 
Pdia6/Erp5 6 5 12 11 13 14 7.67 12.67 0.07 
Hspd1/Hsp60 7 7 9 13 7 9 7.67 9.67 0.49 
Hsp90aa1 4 3 4 7 6 9 3.67 7.33 0.08 
Prdx2 2 8 8 5 7 3 6 5 0.53 
Hspa9/Grp75 5 2 6 5 5 7 4.33 5.67 0.53 
Crtap 3 4 4 2 3 3 3.667 2.67 0.44 
Hspa4 3 4 5 5 4 2 4 3.67 0.77 
GAPDH 19 18 20 19 13 21 19 17.67 0.56 
Cartilage protein pools were analyzed by LC-MS/MS and the data analyzed using Mascot against the UniProt mouse database and validated with Scaffold using peptide/protein 
confidence values of 0.95 and 0.99, respectively. Positively identified proteins were defined as those having a number of matched peptide spectra ≥2. Three biological replicates 
were used in all experiments (wt 1-3 and rdw 1-3) and statistical significance was determined using the beta-binomial test with P<0.05 considered significant. Only calreticulin and 
peroxiredoxin-1 showed a significant increase (*) in the number of individual spectra in Col2-Tgrdw (rdw) cartilage compared with wild type (wt). 
Table 2. Proteins interacting with Tgrdw 
  Unique matching peptides  
Protein name MW (kDa) wt rdw Function 
Thyroglobulin (Tg) 304 0 35 – 
Protein disulfide-isomerase A6 (Pdia6) 48 0 6 Chaperone that inhibits aggregation of misfolded proteins 
Heat shock 70kD protein 5 (Hspa5 or BiP) 72 3 6 Involved in folding and protein assembly in the ER 
Ribosomal protein S4, X-linked (Rps4x) 30 0 5 Component of the 40S subunit 
UDP-glucose 6-dehydrogenase (Ugdh) 47 0 5 Involved in the biosynthesis of GAGs 
Ribosomal protein S16 (Rps16) 16 0 5 Component of the 40S subunit 
Annexin A2 (Anxa2) 39 0 5 Regulates cell growth and cell transduction pathways; 
enhances osteoclast formation and bone resorption 
Ribosomal protein S2 (Rps2) 29 0 4 Component of the 40S subunit 
Inorganic pyrophosphatase 1 (Ppa1) 33 0 4 Catalyses the hydrolysis of pyrophosphate to inorganic 
phosphate 
The list of proteins co-immunoprecipitating with Tgrdw and identified by mass-spectrometry. The number of unique matching peptides that were identified in cartilage samples from 
transgenic Col2-Tgrdw animals (rdw) are compared with the negative wild-type (wt) control. A number of unique matching peptides equal to, or greater than, 4 indicates an almost 
certain identification, whereas a value smaller than 4 indicates a possible identification. Only those proteins with a number of unique matching peptides ≥4 are included in this table. 
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levels of BiP (Chessler and Byers, 1992) and are proposed to induce
an ‘aggregated protein response’ (APR) (Makareeva et al., 2011).
Finally, models of serpinopathies in which the aggregation of
misfolded insoluble α1-antitrypsin triggers an alternative ER stress
response [termed ER overload response (EOR)] that is independent
of the UPR but involves the activation of NF-κB signalling is another
example (Ekeowa et al., 2010). Even though our approach relied
upon the expression of an exogenous mutant protein, it none-the-
less confirms that a transcriptional UPR is not the only response
that might be induced by mutant protein retention and chronic ER
stress. Understanding why different misfolded mutant proteins
evoke different responses (i.e. UPR versus APR versus EOR) is an
exciting new area of research in human pathobiology, and our
recent finding that the consequences of individual mutations on
protein misfolding and/or aggregation differs between Matn3
V194D and Comp DelD469 mutant mice begins to provide a
molecular explanation for why some misfolded mutant proteins
induce a UPR and others do not (Bell et al., 2013).
Immunohistochemical analysis (IHC) confirmed that the
retention of mutant Tg in the chondrocytes of Col2-Tgrdw mice did
not result in the co-retention of cartilage ECM molecules such as
types II and X collagen, aggrecan and COMP, which were normally
distributed within the ECM of transgenic mouse cartilage. For
example, in Col2-Tgrdw mice, type II collagen was localized
predominantly to the ECM of the resting and proliferating zones,
type X collagen was restricted to the hypertrophic zone, whereas
aggrecan and COMP had the expected pericellular distribution.
Moreover, the extractability of numerous ECM components was
similar in Col2-Tgrdw mice compared with wild-type cartilage,
confirming that there was no major alteration to the ECM network
at 3 weeks of age. The extractability of α1(II) collagen was slightly
decreased in Col2-Tgrdw cartilage following treatment with the low
ionic buffer 1; however, this did not seem to have severe
consequences on ECM composition as revealed by the normal
distribution of type II collagen in Col2-Tgrdw ECM following IHC.
Furthermore, although α1(IX) collagen and osteomodulin showed
increased extractability in buffer 1, the low number of spectral
counts makes the biological relevance of these changes difficult to
interpret. Finally, α3(VI) collagen and fibronectin showed increased
extractability from mutant cartilage in buffer 2, suggesting that the
pericellular matrix (PCM) of mutant chondrocytes might be slightly
altered. Nevertheless, the extraction profile of other PCM-
associated molecules is within normal limits with both the lower
and higher ionic strength buffers, indicating that there are no major
alterations to the pericellular environment.
Microarray experiments also showed no major alteration in the
expression profile of cartilage-specific markers in Col2-Tgrdw mice
compared with wild-type animals at 5 days of age. This analysis
provided further validation that the Col2-Tgrdw transgenic mouse
is a model of chondrodysplasia caused primarily by intracellular/ER
stress without any major ECM alterations.
Increased and/or spatially dysregulated apoptosis and/or decreased
chondrocyte proliferation have previously been ascribed as ‘core
disease mechanisms’ in several mouse models of both phenotypically
related and unrelated chondrodysplasias (Cortes et al., 2009; Forlino
et al., 2005; Gualeni et al., 2010; Nundlall et al., 2010; Piróg-Garcia
et al., 2007; Posey et al., 2009; Raducanu et al., 2009; Sahni et al.,
2001; Suleman et al., 2012; Wang et al., 2007; Wang et al., 2002). We
observed no increase or spatial dysregulation of chondrocyte
apoptosis in the growth plates of Col2-Tgrdw mice, which we have
previously described in our mouse models of PSACH and MED
(Leighton et al., 2007; Piróg-Garcia et al., 2007; Suleman et al., 2012).
This finding was particularly surprising because the expression of
Tgrdw in the thyroid gland of rdw/rdw rats causes protein aggregation
that leads to thyrocyte apoptosis (Menon et al., 2007). This
observation therefore suggests that the expression levels of Tgrdw in
chondrocytes might not be high enough to induce apoptosis. Indeed,
no increase in apoptosis was detected in the thyroid glands of rdw/+
rats, suggesting that high levels of Tgrdw expression are required to
cause a cytotoxic effect (Menon et al., 2007). Interestingly, the
expression levels of Tgrdw in chondrocytes of Col2-Tgrdw mice as
evaluated by microarray analysis were comparable to those of
matrilin-3. Previous studies have shown that the mechanism leading
to MED caused by matrilin-3 mutations involves the induction of a
UPR and dysregulated apoptosis (Leighton et al., 2007; Nundlall et
al., 2010). Therefore the comparable level of Tgrdw expression should
be sufficient to modify apoptosis in growth plate chondrocytes.
Alternatively, the lack of a pro-apoptotic effect of aggregated Tgrdw
in Col2-Tgrdw mouse chondrocytes might be due to cell-specificity.
Indeed, it is possible that some of the consequences of intracellular
aggregation of Tgrdw are cell-dependant and could differ between
thyrocytes and chondrocytes.
Chondrocyte proliferation was reduced by 21% in Col2-Tgrdw
mice compared with wild-type controls. A similar reduction was
found in various mouse models of PSACH and MED, which
showed reduced proliferation rates of 17% (Matn3 V194D)
(Leighton et al., 2007), 18% (Comp D469del) (Suleman et al., 2012)
and 26% (Comp T585M) (Piróg-Garcia et al., 2007). Therefore,
although the expression of mutant Tg in Col2-Tgrdw mouse
chondrocytes was not sufficient to induce a significant UPR
(compared with thyrocytes), it is nonetheless sufficient to produce
a direct effect on chondrocyte proliferation.
Long bone growth occurs through a highly coordinated process
involving proliferation, hypertrophy and finally apoptosis of terminal
hypertrophic chondrocytes at the vascular invasion front. Although
the largest contribution to long bone growth has been ascribed to
the dramatic increase in volume of hypertrophic chondrocytes
(Breur et al., 1991), this process is still dependent upon sufficient
Fig. 5. Apoptosis is not induced, but chondrocyte proliferation is
significantly reduced, in Col2-Tgrdw transgenic mice. (A) The rate of
chondrocyte apoptosis in the proliferative (P) and hypertrophic (H) zones of
the growth plate was analyzed by TUNEL and shown to be comparable
between wild-type (wt; white columns) and Col2-Tgrdw (rdw; black columns)
mice. (B) Chondrocyte proliferation in the proliferative zone of the growth
plate was significantly reduced by 21% (*P<0.01) in Col2-Tgrdw mice (rdw; black
columns) compared with wild-type (wt; white columns) mice.
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chondrocytes entering hypertrophy after proliferation. It therefore
follows that reduced chondrocyte proliferation will have a profound
effect on hypertrophy and indeed our study suggests that reduced
proliferation is sufficient on its own to cause short-limb dwarfism.
To further support this hypothesis, morphometric analysis did not
demonstrate any differences in the overall width of the growth plate
or in the spatial organization of the different zones, whereas the
number of hypertrophic cells per chondrocyte column was
comparable between genotypes.
Finally, as a possible consequence of reduced chondrocyte
proliferation in Col2-Tgrdw mice, we also observed areas of
hypocellularity in the growth plate, a feature common to other mouse
models of chondrodysplasia (Baradaran-Heravi et al., 2012; Leighton
et al., 2007; Pfander et al., 2004; Piróg-Garcia et al., 2007; Suleman
et al., 2012; Zaucke and Grässel, 2009), which has previously been
attributed to increased and/or dysregulated apoptosis.
In summary, the data presented in this paper demonstrate that
mutant protein retention and intracellular stress, without
alterations to the secretion and assembly of the ECM, can directly
cause chondrodysplasia in mice by reducing chondrocyte
proliferation in the epiphyseal growth plate. We propose that
reduced chondrocyte proliferation alone is sufficient to cause
reduced long bone growth independently of increased and/or
spatially dysregulated chondrocyte apoptosis. These important
findings will significantly increase our understanding of the relative
contributions of various disease mechanisms to the initiation and
progression of chondrodysplasia. Furthermore, our study will help
in delineating specific disease mechanisms that will pave the way
for the identification of relevant therapeutic targets that influence
detrimental changes in chondrocyte phenotype.
MATERIALS AND METHODS
Generation of Col2-Tgrdw transgenic mice and genotyping by PCR
and real-time qPCR
The mouse collagen type II (Col2) promoter cloned into pBluescript
was a kind gift from Dr Attila Aszodi (LMU, Munich). The 8.5-kb
cDNA encoding the rdw mutant form of Tg, including the start
codon, three contiguous Myc tags and the polyadenylation site (Lee
et al., 2009), was subcloned into an EcoRV site within the 3 end
of the Col2 promoter. The construct was then removed from the
vector by digestion with BssHII and the DNA was purified for
pronuclear injection into fertilized oocytes collected from FVB
mice, which were subsequently implanted into pseudo-pregnant
foster mothers.
The resulting offspring were assessed for the presence of the
transgene by PCR between the Col2 promoter and the Tgrdw cDNA
using the following primers: Col2-Gen forward: 5-
GCACCGTTCTCATGTGCAGG-3 and Tgrdw-Gen reverse: 5-
TTCCATCTTCAGAGCACTGG-3. Chimeras that were positive
for the transgene (showing a band at ~360 bp) were mated with
wild-type C57BL/6 mice, and heterozygous F1 offspring were mated
together to generate wild-type, heterozygous and homozygous
mice. Heterozygous and homozygous genotypes were determined
by quantitating the relative levels of the transgene to that of the
type X collagen gene (Col10a1) using real-time qPCR on genomic
DNA with the following primers: Col2-Rt forward: 5-CATT -
CTTGGAGAACGCAGG-3; Tgrdw-Rt reverse: 5-ATGTTGGC -
TGCTACCAGG-3; Col10a1-Rt forward: 5-CTTCCTGTCAAG -
CTCATCC-3; Col10a1-Rt reverse: 5-TAGGATTGCTGAGT -
GCTCC-3. Wild-type genomic DNA was used as a control and a
‘no template’ control was included to monitor contamination. All
samples were run in duplicate using the SYBR® Green (Applied
Biosystems) PCR protocol on a Chromo4™ real-time PCR system
(Bio-Rad). Only wild-type and homozygous animals were
subsequently used in this study.
Growth curves, X-rays and bone length measurements
Mice were weighed at 3, 6 and 9 weeks of age, and these values
were used to generate growth curves. Mice were also radiographed
at 3, 6 and 9 weeks of age using an X-ray specimen radiography
system (Faxitron) and X-ray films (Amersham Hyperfilm).
Individual bone lengths were measured from scanned radiographic
images using propriety software (Certus Technology Associates
Limited, Exeter, UK).
Histology and IHC of fixed tissues
Hind limbs were dissected from wild-type and transgenic mice.
Bones were cleaned of surrounding soft tissues and then fixed at
room temperature overnight in either 4% paraformaldehyde (PFA,
Sigma) or in a solution of 5% acetic acid in ethanol. Bone
decalcification was performed in 20% EDTA at pH 7.4. Samples
were then rinsed in distilled water, dehydrated through a series of
increasing alcohols, cleared in xylene and embedded in paraffin
wax. Sagittal sections 5 μm thick were cut using an HM 355S
microtome (MicRom), collected on positively charged superfrost
slides (VWR) and dried overnight prior to classical histological
staining or IHC. For haematoxylin and eosin staining, slides were
de-waxed in xylene, rehydrated through a series of decreasing
alcohols, stained, dehydrated and cleared in xylene using an
automatic stainer (ThermoShandon Ltd) prior to mounting using
the xylene-based mounting medium Pertex (Leica). For 5-bromo-
2-deoxyuridine (BrdU) IHC, 3-week-old mice were injected
intraperitoneally with 10 μl BrdU labeling solution/g body weight
(Amersham) 2  hours before sacrifice. IHC using anti-Myc-tag
antibody clone 4A6 (Millipore, #16-213, 1:300), anti-collagen II
antibody (Abcam, #ab54236, prediluted), anti-collagen X antibody
(Rajpar et al., 2009), anti-COMP antibody (Genetex, #GTX14515,
1:500) and anti-BrdU antibody (Invitrogen, #B35138, prediluted)
was performed on 5% acetic acid in ethanol-fixed samples, whereas
IHC using anti-aggrecan antibody (Santa Cruz Biotechnology, sc-
25674, 1:25) and DeadEnd™ fluorometric terminal deoxynucleotidyl
transferase dUTP nick end labelling (TUNEL) assay (Promega) for
the detection of apoptotic cells were performed on PFA-fixed
samples. After staining, microscopical images of the samples were
collected using the Axiovision microscope software (Zeiss).
Chondrocyte isolation, SDS-PAGE and western blotting of
chaperones
Cartilage was dissected from the ribs of 5-day-old animals as
previously described (Nundlall et al., 2010) and digested to release
the chondrocytes. Chondrocytes were then passed through a 70-
μm cell strainer, washed in Dulbecco’s modified Eagle’s medium
(DMEM) containing 20% foetal bovine serum (FBS), centrifuged
for 5 minutes at 350 g, washed in phosphate buffered saline (PBS),
centrifuged for 5 minutes at 350 g and re-suspended in 1 ml of PBS
for cell counting. Aliquots of 105 cells were re-suspended in 20 μl
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of 1× SDS-PAGE buffer, either with the addition of 5 μl of 1M DTT
(reduced samples) or not (unreduced samples) and incubated at
95°C for 5 minutes prior to loading on 4-12% SDS-PAGE gels. The
gel was electroblotted onto a nitrocellulose membrane, which was
blocked with 5% skimmed milk powder in 1% Tween in PBS either
at room temperature for 1 hour or at 4°C overnight. Protein
detection was then performed using the antibodies anti-Myc-tag
clone 4A6 (Millipore, #16-213, 1:2000), anti-ERp57 (Abcam,
#27985, 1:500), anti-ERp72 (Santa Cruz, #G2506, 1:500), anti-PDI
(Enzo, #ADI-SPA-890, 1:500) and anti-GAPDH (Millipore,
MAB374, 1:500). When required, the blots were quantified by
densitometry analysis using the ImageJ software (Abramoff et al.,
2004) and normalized to GAPDH.
Microarray hybridization
RNA was isolated from the rib chondrocytes of 5-day-old mice, as
previously described (Nundlall et al., 2010). RNA extracted from
the mice of three litters (on average eight pups per litter) of the
same genotype was pooled and used for microarray analysis. RNA
quality was tested using the RNA 6000 Nano Assay and analyzed
using the Agilent 2100 Bioanalyser (Agilent Technologies). RNA
concentration was assessed using the Nanodrop ultra low volume
spectrophotometer (Nanodrop Technologies). The hybridization
cocktail was hybridized to the Mouse 430_2 oligonucleotide array
(Affymetrix). Arrays were read, processed and analyzed as
previously described (Suleman et al., 2012).
Real-time qPCR
mRNA was isolated from the rib chondrocytes of 5-day-old mice
as previously described (Nundlall et al., 2010). mRNA extracted
from three separate litters per genotype (on average eight pups per
litter) was retrotranscribed to cDNA using random hexamer
primers (Superscript III, Invitrogen), and real-time qPCR was
performed using the SYBR® Green (Applied Biosystems) PCR
protocol on a Chromo4™ real-time PCR system (Bio-Rad). Primer
sequences were: Grp78/BiP forward 5-GGCACCTTCGAT -
GTGTCTCTTC-3; Grp78/BiP reverse 5-TCCATGACCCGC -
TGATCAA-3; Grp94 forward 5-TAAGCTGTATGTACGCC -
GCGT-3; Grp94 reverse 5-GGAGATCATCGGAATCCACAAC-
3; Cnx forward 5-TGATTTCCTCTCCCTCCCCTT-3; Cnx
reverse 5-CACTGGAACCTGTTGATGGTGA-3; Crt forward
5-GCTACGTGAAGCTGTTTCCGA-3; Crt reverse 5-ACAT -
GAACCTTCTTGGTGCCAG-3; Erp72 forward 5-AGTATGAG -
CCCAGGTTCCACGT-3 and Erp72 reverse 5-AGAAGTCT -
TACGATGGCCCACC-3. Each experiment included ‘no template’
controls, was run in duplicate, and had an 18S RNA control (18S
forward 5-GTAACCCGTTGAACCCCATT-3; 18S reverse 5-
CCATCCAATCGGTAGTAGCG-3).
Immunoprecipitation of Myc-tagged Tg and interacting proteins
For immunoprecipitation experiments, cartilage was dissected
from the ribs of 5-day-old animals as previously described (Nundlall
et al., 2010) and digested to release the chondrocytes. Chondrocytes
were then passed through a 70-μm cell strainer, washed in DMEM
containing 20% FBS, centrifuged for 5 minutes at 350 g, washed in
PBS, centrifuged for 5 minutes at 350 g and incubated in 25 mM
N-ethylmaleimide (NEM) in PBS for 20 minutes on ice in order to
preserve protein-protein interaction. Cells were then centrifuged
at 350 g for 5 minutes, washed in PBS and centrifuged again at 350
g for 5 minutes before being lysed for 5 minutes on ice in 25 mM
Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100,
5% glycerol, 0.5 mM PMSF. Cell lysates were centrifuged at 13,600 g
for 10 minutes at 4°C and protein content was assessed on the
supernatants using the BCA assay. The ProFound c-Myc Tag IP/Co-
IP Kit (Thermo Scientific) was used according to the manufacturer’s
instructions to precipitate the mutant Myc-tagged Tg together with
interacting proteins.
To confirm that the protein of interest was correctly precipitated,
a control western blotting experiment was performed. Samples were
then loaded onto 10% SDS-PAGE gels and run into the gels for 3
minutes at 220 V. Gels were stained for 5 minutes with InstantBlue
Coomassie-based stain (Expedeon) and washed with distilled water
overnight. MS was used to identify the co-precipitated proteins
interacting with mutant Tg.
Sequential protein extractions of mouse cartilage
The femoral heads were dissected from 3-week-old mice, snap
frozen in liquid nitrogen and stored at −80°C. On the day of the
extraction, samples were thawed, roughly cut into small pieces and
precisely weighted. Sequential extraction of the proteins was
performed as described elsewhere (Nicolae et al., 2007). The first
extraction was performed in 0.15 M NaCl, 50  mM Tris, pH 7.4
(buffer 1) with EDTA-free protease inhibitors (Roche); the second
extraction was performed in 1 M NaCl, 10  mM EDTA, 50  mM
Tris, pH 7.4 (buffer 2) with EDTA-free protease inhibitors; and the
third extraction was performed in 4 M GuHCl, 10  mM EDTA,
50 mM Tris, pH 7.4 (buffer 3) with EDTA-free protease inhibitors.
The extracted proteins were ethanol precipitated, air dried, re-
suspended in SDS-PAGE sample buffer with 0.1 M DTT and boiled
at 95°C for 5 minutes.
Mass spectrometry (LC-MS/MS) analysis of cartilage extractions
Aliquots (20 μl) of femoral head cartilage extracts were run on 4-
12% SDS-PAGE for 4 minutes (at 200 V). Total protein pools were
cut from the gel before dehydration, reduction, alkylation and
washing. Samples were digested overnight with trypsin at 37°C and
analyzed by LC-MS/MS with a NanoAcquity LC (Waters,
Manchester, UK) and LTQ Velos (Thermo Fisher Scientific,
Waltham, MA) mass spectrometer. Peptides were concentrated on
a pre-column (20 mm×180 μm i.d., Waters) and separated using a
gradient from 99% A (0.1% formic acid in water) and 1% B (0.1%
formic acid in acetonitrile) to 25% B, in 45 minutes at 200 nl/minute,
using a 75 mm×250 μm i.d. 1.7 μm BEH C18, analytical column
(Waters). Peptides were selected for fragmentation automatically
by data-dependent analysis.
Bioinformatic processing of LC-MS/MS data
Data were interrogated using Mascot version 2.2 (Matrix Science,
UK) against the UniProt database (version 2011-05) with taxonomy
of Mus musculus and the following search parameters selected:
fragment tolerance: 0.6 Da; parent tolerance: 0.5 Da; fixed
modifications allowed: +57 on C (carbamidomethyl), +16 on M
(oxidation); max missed cleavages: 1. Mascot search results were
validated using Scaffold version 3.3.1 (Proteome Software, Portland,
OR) to assign confidence values to peptide/protein matches, where
Peptide/Protein Prophet algorithm confidence values of 0.7 and 0.99
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were used, respectively. Identified proteins were defined as having
a number of matched peptide spectra ≥2, and the unweighted
spectral count was used as a measure of quantification. These
parameters constrained the protein false discovery rate (FDR) to
≤0.2% in all analyses. Three biological replicates were used in all
experiments. The number of spectra identified for each protein was
compared between wild-type and Col2-Tgrdw mice using the beta-
binomial test in R (version 2.14.2, BetaBinomial package). A P-value
<0.05 was considered significant.
General statistical analysis
Where applicable, statistical differences between the different
groups tested were evaluated using Student’s t-test and results were
expressed as means ± s.e.m. A value of P<0.05 was considered
statistically significant.
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